UPDATE - Canaccord Genuity Upgraded Gen-Probe (GPRO) to Buy; Outlook still attractive
Tweet
Share
E-mailGet Alerts GPRO Hot Sheet
Price: $0.63 +1.61%
Rating Summary:
4 Buy, 11 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 11 Hold, 6 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Canaccord Genuity upgraded Gen-Probe (NASDAQ: GPRO) from Hold to Buy, maintains price target of $67.00.
Canaccord analyst, Jeffrey Frelick, says, "We previously lowered our rating on GPRO in April due to the stock reacting to takeout speculation by trading around $80. With the stock now trading 19% below pre-takeout levels of $68/share, we believe the current share price, a major new product cycle and the company’s position as a leader in molecular diagnostics make the stock very attractive."
To see more ratings changes on GPRO, Click Here
Canaccord analyst, Jeffrey Frelick, says, "We previously lowered our rating on GPRO in April due to the stock reacting to takeout speculation by trading around $80. With the stock now trading 19% below pre-takeout levels of $68/share, we believe the current share price, a major new product cycle and the company’s position as a leader in molecular diagnostics make the stock very attractive."
To see more ratings changes on GPRO, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GoPro promotes CFO Brian Tratt to senior vice president role
- Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy
- Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
